NS-065/NCNP-01

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	17

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 10 of 17 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-000122-10-GR (EUCTR)	25/11/2021	13/10/2021	A Phase 3 study of Viltolarsen in boys with Duchenne Muscular Dystrophy (DMD)	A Phase 3, Multi-center, Open-label Extension Study to Assess the Safety and Efficacy of Viltolarsen ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Chile;Russian Federation;United Kingdom;I ...
2	EUCTR2019-002076-13-NO (EUCTR)	08/09/2021	18/02/2021	This is a randomized, double-blind, Placebo-controlled sudy to evaluate the Efficacy and Safety of V ...	A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy an ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Russian Federation;Chile;United Kingdom;I ...
3	EUCTR2020-003653-30-ES (EUCTR)	26/07/2021	15/12/2021	A Phase 2 Open-label Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambula ...	A Phase 2 Open-label Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambula ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	20	Phase 2	United States;Spain;Turkey;Russian Federation;Italy;China
4	EUCTR2021-000122-10-NL (EUCTR)	30/06/2021	08/04/2021	A Phase 3 study of Viltolarsen in boys with Duchenne Muscular Dystrophy (DMD)	A Phase 3, Multi-center, Open-label Extension Study to Assess the Safety and Efficacy of Viltolarsen ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Chile;Russian Federation;United Kingdom;I ...
5	EUCTR2021-000122-10-ES (EUCTR)	15/06/2021	30/07/2021	A Phase 3 study of Viltolarsen in boys with Duchenne Muscular Dystrophy (DMD)	A Phase 3, Multi-center, Open-label Extension Study to Assess the Safety and Efficacy of Viltolarsen ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Chile;Russian Federation;United Kingdom;I ...
6	EUCTR2020-003653-30-IT (EUCTR)	08/06/2021	08/06/2021	This is an Open-label Study to evaluate the Safety, Tolerability, and Efficacy of Viltolarsen in Amb ...	A Phase 2 Open-label Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambula ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: [NS-065/NCNP-01] INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	20	Phase 2	United States;Spain;Turkey;Russian Federation;China;Italy
7	EUCTR2021-000122-10-IT (EUCTR)	26/04/2021	08/06/2021	A Phase 3 study of Viltolarsen in boys with Duchenne Muscular Dystrophy (DMD)	A Phase 3, Multi-center, Open-label Extension Study to Assess the Safety and Efficacy of Viltolarsen ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: [NS-065/NCNP-01] INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Chile;Russian Federation;United Kingdom;I ...
8	EUCTR2019-002076-13-GR (EUCTR)	12/11/2020	24/09/2020	This is a randomized, double-blind, Placebo-controlled sudy to evaluate the Efficacy and Safety of V ...	A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy an ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Russian Federation;Chile;United Kingdom;I ...
9	EUCTR2019-002076-13-NL (EUCTR)	03/03/2020	25/11/2019	This is a randomized, double-blind, Placebo-controlled sudy to evaluate the Efficacy and Safety of V ...	A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy an ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Hong Kong;Taiwan;Greece;Spain;Ukraine;Turkey;Chile;Russian Federation;United Kingdom;I ...
10	EUCTR2019-002076-13-GB (EUCTR)	02/03/2020	16/09/2019	This is a randomized, double-blind, Placebo-controlled sudy to evaluate the Efficacy and Safety of V ...	A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy an ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Product Name: Viltolarsen Product Code: NS-065/NCNP-01 INN or Proposed INN: VILTOLARSEN	NS Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	74	Phase 3	United States;Taiwan;Spain;Turkey;Chile;Russian Federation;United Kingdom;Italy;France;Canada;Belgiu ...

First Previous1 2Next Last